Skip to main content

Advertisement

Log in

Increase in plasma acyl ghrelin levels is associated with abatement of dyspepsia following Helicobacter pylori eradication

Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

Ghrelin has been indicated as one of the etiological factors in functional dyspepsia (FD).

Methods

We analyzed 179 patients with FD (based on the Rome III criteria) and 103 asymptomatic healthy individuals (controls) who had undergone endoscopy at Seoul National University Bundang Hospital from February 2011 to June 2014. FD patients were classified into three groups by means of a self-reported questionnaire: patients with postprandial distress syndrome (PDS; n = 49), patients with epigastric pain syndrome (EPS; n = 45), and patients with a combination of these two types (mixed group; n = 85). The fasting blood levels of acyl ghrelin and desacyl ghrelin and messenger RNA (mRNA) expression of preproghrelin in the fundic mucosa were measured by ELISAs and reverse transcription quantitative real-time PCR, respectively. One year after participant enrollment, they were measured again in 79 participants and the changes in the values were compared according to Helicobacter pylori eradication or symptom response.

Results

Plasma acyl ghrelin level was lower in the PDS group than in the control and EPS groups (control group 14.1 fmol/mL, PDS group 8.9 fmol/mL, EPS group 13.8 fmol/mL, mixed group 11.3 fmol/mL; P = 0.003 and P = 0.012, respectively). One year after the eradication of H. pylori, plasma acyl ghrelin level was increased and gastric preproghrelin mRNA expression was upregulated (P = 0.004 and P < 0.001, respectively). Patients with abatement of symptoms demonstrated an increase in plasma acyl ghrelin level (from 11.51 to 21.00 fmol/L, P = 0.040).

Conclusions

Our results suggest that plasma acyl ghrelin plays a role in the development of PDS. H. pylori eradication upregulates preproghrelin mRNA expression and increases plasma acyl ghrelin level, contributing to the abatement of PDS symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Abbreviations

BMI:

Body mass index

EPS:

Epigastric pain syndrome

FD:

Functional dyspepsia

GADPH:

Glyceraldehyde 3-phosphate dehydrogenase

GI:

Gastrointestinal

mRNA:

Messenger RNA

PDS:

Postprandial distress syndrome

PG I:

Pepsinogen I

PG II:

Pepsinogen II

PPI:

Proton-pump inhibitor

References

  1. Wu JC. Psychological co-morbidity in functional gastrointestinal disorders: epidemiology, mechanisms and management. J Neurogastroenterol Motil. 2012;18:13–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Stanghellini V, Tosetti C, Paternico A, et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology. 1996;110:1036–42.

    Article  CAS  PubMed  Google Scholar 

  3. Tack J, Caenepeel P, Fischler B, et al. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology. 2001;121:526–35.

    Article  CAS  PubMed  Google Scholar 

  4. Hwang SW, Kim N, Jung HK, et al. The association of SLC6A4 5-HTTLPR and TRPV1 945G>C with functional dyspepsia in Korea. J Gastroenterol Hepatol. 2014;29:1770–7.

    Article  CAS  PubMed  Google Scholar 

  5. Yano JM, Yu K, Donaldson GP, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015;161:264–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Khoo J, Rayner CK, Feinle-Bisset C, et al. Gastrointestinal hormonal dysfunction in gastroparesis and functional dyspepsia. Neurogastroenterol Motil. 2010;22:1270–8.

    Article  CAS  PubMed  Google Scholar 

  7. Akamizu T, Iwakura H, Ariyasu H, et al. Ghrelin and functional dyspepsia. Int J Pept. 2010. doi:10.1155/2010/548457.

    PubMed  PubMed Central  Google Scholar 

  8. Jeffery PL, McGuckin MA, Linden SK. Endocrine impact of Helicobacter pylori: focus on ghrelin and ghrelin o-acyltransferase. World J Gastroenterol. 2011;17:1249–60.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Wren A, Seal L, Cohen M, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001;86:5992–5.

    Article  CAS  PubMed  Google Scholar 

  10. Goebel-Stengel M, Hofmann T, Elbelt U, et al. The ghrelin activating enzyme ghrelin-O-acyltransferase (GOAT) is present in human plasma and expressed dependent on body mass index. Peptide. 2013;43:10–3.

    Google Scholar 

  11. Bednarek MA, Feighner SD, Pong SS, et al. Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J Med Chem. 2000;43:4370–6.

    Article  CAS  PubMed  Google Scholar 

  12. Van Der Lely AJ, Tschop M, Heiman ML, et al. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev. 2004;25:426–57.

    Article  PubMed  Google Scholar 

  13. Shindo T, Futagami S, Hiratsuka T, et al. Comparison of gastric emptying and plasma ghrelin levels in patients with functional dyspepsia and non-erosive reflux disease. Digestion. 2009;79:65–72.

    Article  CAS  PubMed  Google Scholar 

  14. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377–90.

    Article  PubMed  Google Scholar 

  15. Suzuki H, Moayyedi P. Helicobacter pylori infection in functional dyspepsia. Nat Rev Gastroenterol Hepatol. 2013;10:168–74.

    Article  PubMed  Google Scholar 

  16. Budzyński J, Kłopocka M. Brain-gut axis in the pathogenesis of Helicobacter pylori infection. World J Gastroenterol. 2014;20:5212–25.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Isomoto H, Ueno H, Saenko VA, et al. Impact of Helicobacter pylori infection on gastric and plasma ghrelin dynamics in humans. Am J Gastroenterol. 2005;100:1711–20.

    Article  CAS  PubMed  Google Scholar 

  18. Boltin D, Niv Y. Ghrelin, Helicobacter pylori and body mass: is there an association? Isr Med Assoc J. 2012;14:130–2.

    PubMed  Google Scholar 

  19. Nweneka CV, Prentice AM. Helicobacter pylori infection and circulating ghrelin levels-a systematic review. BMC gastroenterol. 2011;11:7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Song KH, Jung HK, Min BH, et al. Development and validation of the Korean Rome III questionnaire for diagnosis of functional gastrointestinal disorders. J Neurogastroenterol Motil. 2013;19:509–15.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Noh YW, Jung HK, Kim SE, Jung S. Overlap of erosive and non-erosive reflux diseases with functional gastrointestinal disorders according to Rome III criteria. J Neurogastroenterol Motil. 2010;16:148–56.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Kim SE, Park YS, Kim N, et al. Effect of Helicobacter pylori eradication on functional dyspepsia. J Neurogastroenterol Motil. 2013;19:233–43.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol. 1996;20:1161–81.

    Article  CAS  PubMed  Google Scholar 

  24. Fung JN, Seim I, Wang D, et al. Expression and in vitro functions of the ghrelin axis in endometrial cancer. Horm Cancer. 2010;1:245–55.

    Article  CAS  PubMed  Google Scholar 

  25. Kim HY, Kim N, Kang JM, et al. Clinical meaning of pepsinogen test and Helicobacter pylori serology in the health check-up population in Korea. Eur J Gastroenterol Hepatol. 2009;21:606–12.

    Article  PubMed  Google Scholar 

  26. Suzuki H, Matsuzaki J, Fukushima Y, et al. Randomized clinical trial: rikkunshito in the treatment of functional dyspepsia—a multicenter, double-blind, randomized, placebo-controlled study. Neurogastroenterol Motil. 2014;26:950–61.

    Article  CAS  PubMed  Google Scholar 

  27. Kang JM, Kim N, Yoo JY, et al. The role of serum pepsinogen and gastrin test for the detection of gastric cancer in Korea. Helicobacter. 2008;13:146–56.

    Article  PubMed  Google Scholar 

  28. Shin A, Camilleri M, Busciglio I, et al. The ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitus. Clin Gastroenterol Hepatol. 2013;11:1453–9.e4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Takiguchi S, Hiura Y, Takahashi T, et al. Effect of rikkunshito, a Japanese herbal medicine, on gastrointestinal symptoms and ghrelin levels in gastric cancer patients after gastrectomy. Gastric Cancer. 2013;16:167–74.

    Article  PubMed  Google Scholar 

  30. Arai M, Matsumura T, Tsuchiya N, et al. Rikkunshito improves the symptoms in patients with functional dyspepsia, accompanied by an increase in the level of plasma ghrelin. Hepatogastroenterology. 2011;59:62–6.

    Google Scholar 

  31. Nishizawa T, Suzuki H, Nomoto Y, et al. Enhanced plasma ghrelin levels in patients with functional dyspepsia. Aliment Pharmacol Ther. 2006;24:104–10.

    Article  Google Scholar 

  32. Shinomiya T, Fukunaga M, Akamizu T, et al. Plasma acylated ghrelin levels correlate with subjective symptoms of functional dyspepsia in female patients. Scand J Gastroenterol. 2005;40:648–53.

    Article  CAS  PubMed  Google Scholar 

  33. Vakil N, Halling K, Ohlsson L, et al. Symptom overlap between postprandial distress and epigastric pain syndromes of the Rome III dyspepsia classification. Am J Gastroenterol. 2013;108:767–74.

    Article  PubMed  Google Scholar 

  34. Banks WA, Tschöp M, Robinson SM, et al. Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther. 2002;302:822–7.

    Article  CAS  PubMed  Google Scholar 

  35. Luckman SM, Rosenzweig I, Dickson SL. Activation of arcuate nucleus neurons by systemic administration of leptin and growth hormone-releasing peptide-6 in normal and fasted rats. Neuroendocrinology. 1999;70:93–100.

    Article  CAS  PubMed  Google Scholar 

  36. Suzuki H, Matsuzaki J, Hibi T. Ghrelin and oxidative stress in gastrointestinal tract. J Clin Biochem Nutr. 2011;48:122–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Suzuki H, Matsuzaki J, Hibi T. What is the difference between Helicobacter pylori-associated dyspepsia and functional dyspepsia? J Neurogastroenterol Motil. 2011;17:124–30.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Isomoto H, Ueno H, Nishi Y, et al. Circulating ghrelin levels in patients with various upper gastrointestinal diseases. Dig Dis Sci. 2005;50:833–8.

    Article  CAS  PubMed  Google Scholar 

  39. Suzuki H, Masaoka T, Hosoda H, et al. Helicobacter pylori infection modifies gastric and plasma ghrelin dynamics in Mongolian gerbils. Gut. 2004;53:187–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Roper J, Francois F, Shue PL, et al. Leptin and ghrelin in relation to Helicobacter pylori status in adult males. J Clin Endocrinol Metab. 2008;93:2350–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Osawa H, Kita H, Ohnishi H, et al. Changes in plasma ghrelin levels, gastric ghrelin production, and body weight after Helicobacter pylori cure. J Gastroenterol. 2006;41:954–61.

    Article  CAS  PubMed  Google Scholar 

  42. Czesnikiewicz-Guzik M, Loster B, Bielanski W, et al. Implications of oral Helicobacter pylori for the outcome of its gastric eradication therapy. J Clin Gastroenterol. 2007;41:145–51.

    Article  PubMed  Google Scholar 

  43. Kawashima J, Ohno S, Sakurada T, et al. Circulating acylated ghrelin level decreases in accordance with the extent of atrophic gastritis. J Gastroenterol. 2009;44:1046–54.

    Article  CAS  PubMed  Google Scholar 

  44. Moayyedi P, Soo S, Deeks JJ, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2006;(2):CD002096.

  45. Miwa H, Kusano M, Arisawa T, et al. Evidence-based clinical practice guidelines for functional dyspepsia. J Gastroenterol. 2015;50:125–39.

    Article  CAS  PubMed  Google Scholar 

  46. Miwa H, Hirai S, Nagahara A, et al. Cure of Helicobacter pylori infection does not improve symptoms in non-ulcer dyspepsia patients—a double-blind placebo-controlled study. Aliment Pharmacol Ther. 2000;14:317–24.

    Article  CAS  PubMed  Google Scholar 

  47. Gwee K-A, Teng L, Wong R-K, et al. The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 2009;21:327–34.

    Article  Google Scholar 

  48. Barkan AL, Dimaraki EV, Jessup SK, et al. Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient growth hormone levels. J Clin Endocrinol Metab. 2003;88:2180–4.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by a Korean Society of Neurogastroenterology and Motility grant in 2011. The authors are indebted to J. Patrick Barron, Seoul National University Bundang Hospital, for his pro bono editing of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nayoung Kim.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 27 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Choi, Y.J., Kim, N., Yoon, H. et al. Increase in plasma acyl ghrelin levels is associated with abatement of dyspepsia following Helicobacter pylori eradication. J Gastroenterol 51, 548–559 (2016). https://doi.org/10.1007/s00535-015-1124-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-015-1124-6

Keywords

Navigation